Objection pursuant to Rule 112(2) and (3) extending the approval period of 8-hydroxyquinoline

Date: 18.10.2022 · Reference: B9-0460/2022

endocrine disruptor plant health product market approval product safety health risk plant health control precautionary principle
Overall Result: 349 For
349 For
275 Against
14 Abstention
229 Did not vote
Filter by Country
← Go back